scholarly journals Concurrent Hip Pain and Skull Lump as the First Manifestations of a Silent Follicular Thyroid Carcinoma

Reports ◽  
2020 ◽  
Vol 3 (4) ◽  
pp. 27 ◽  
Author(s):  
Kunta Setiaji ◽  
Widya Surya Avanti ◽  
Hanggoro Tri Rinonce ◽  
Sumadi Lukman Anwar
Keyword(s):  
Thyroid Cancer ◽  
Thyroid Carcinoma ◽  
Follicular Thyroid Carcinoma ◽  
Femoral Fractures ◽  
Distant Metastases ◽  
Metastatic Lesion ◽  
Primary Cancer ◽  
Follicular Thyroid Cancer ◽  
Long Term Prognosis

Follicular thyroid carcinoma is a slowly growing cancer with a generally good long-term prognosis. Distant metastasis from follicular thyroid cancer usually occurs in the lung and bones following a long period after diagnosis and treatment for primary cancer. Occult skull metastasis as the first presentation at diagnosis from follicular thyroid cancer is relatively rare. A 51-year-old woman presented with intermittent pain in her right hip that was treated due to the intensely progressed pain, motor weakness, and difficulty walking. The patient was then referred due to swelling in the forehead. Further evaluation revealed that the frontal swelling and the pathological femoral fractures were manifestations of distant metastases from follicular thyroid cancer. In the presence of swelling in the skull, the metastatic lesion should be considered as a differential diagnosis from a silent primary cancer. This report will be beneficial for general practitioners, surgeons, and internists to recognize unusual distant metastatic manifestations from silent differentiated thyroid cancer.

scholarly journals Clinicopathological and metastasis status of follicular thyroid cancer

2021 ◽  
Vol 63 (9) ◽  
pp. 6-9
Author(s):  
Xuan Hau Nguyen ◽  
◽  
Thi Phuong Anh Nguyen ◽  
Van Quang Le ◽  
◽  
...  
Keyword(s):  
Thyroid Cancer ◽  
Thyroid Carcinoma ◽  
Follicular Thyroid Carcinoma ◽  
Nodal Metastasis ◽  
Follicular Thyroid Cancer ◽  
Male Ratio ◽  
Mean Diameter ◽  
The Mean ◽  
Metastatic Sites ◽  
Undetermined Significance

This study aims to evaluate the clinicopathological and metastasis status of follicular thyroid cancer at K Hospital. We conducted a retrospective combined with prospective cohort study of 48 follicular thyroid carcinoma patients treated by surgery at K hospital from January 2016 to July 2020. The mean age was 44±16.1 and the female/male ratio was 4.3/1. Most patients presented with an asymptomatic and had a unilateral tumor with mean diameter was 21.7±12 mm. 72.9% of tumors were classified as TIRADS 4 on ultrasound, and FNA did not play a big role in the diagnosis of follicular thyroid carcinoma with undetermined significance result in 48.9% of cases. Distant metastasis in 18.8%, the most common metastatic sites were bone, followed by the lungs. The overall rate of nodal metastasis was 31.3%. Cancer in both thyroid lobes had significantly associated with nodal metastasis (p<0.05)

scholarly journals A ‘silent’ skull metastatic follicular thyroid carcinoma mimicking as a benign scalp tumor in a pregnant woman

2017 ◽  
Vol 2017 ◽  
Author(s):  
Tsung-Chun Huang ◽  
Yu-Kai Cheng ◽  
Tsung-Wei Chen ◽  
Yung-Chang Hsu ◽  
En-Wei Liu ◽  
...  
Keyword(s):  
Thyroid Cancer ◽  
Pregnant Woman ◽  
Thyroid Gland ◽  
Thyroid Carcinoma ◽  
Neurological Deficit ◽  
Follicular Thyroid Carcinoma ◽  
Follicular Thyroid Cancer ◽  
Image Study ◽  
Thyroglobulin Level ◽  
Cranial Metastasis

Summary Thyroid cancer with cranial metastasis in a pregnant woman is very rare. In the literature, most cases are diagnosed early from neurogenic signs or symptomatic thyroid gland. Pregnancy also contributes to a hesitation toward early surgical and medical treatments. We reported a scalp tumor in a physically healthy 37-year-old pregnant female with a follicular thyroid carcinoma (FTC) with lung, bone and cranial metastasis in initial presentation. Silent neurogenic and physical examinations make an early diagnosis very challenging. Resection of scalp and intracranial tumor, a thyroidectomy, post-operative radioactive iodine therapy and tyrosine kinase inhibitors were employed as treatment. The scalp tumor was confirmed as a metastatic follicular thyroid carcinoma via positive immunoreactivity for thyroglobulin and thyroid transcription factor 1 in tumor cells. Blood examination revealed an elevated thyroglobulin level (>5335 ng/mL). The patient was discharged without any neurological deficit. An asymptomatic scalp tumor in a pregnant woman with a normal thyroid disease history needs differential diagnosis from intracranial origin. Rapid progression and an elevated thyroglobulin level are the indicators that further image study is needed. Aggressive surgical excision of resectable thyroid gland and metastatic tumor are essential for a longer survival rate. There is nothing to indicate that a post-partum operation will worsen prognosis. Learning points: Follicular thyroid cancer with cranial metastasis in initial presentation can be asymptomatic. Follicular thyroid cancer with cranial metastasis in a pregnant woman can be treated after delivery. Rapid enlargement of scalp tumor is indicated for further image study even in a patient without any neurological deficit.

scholarly journals AKT Activation Promotes Metastasis in a Mouse Model of Follicular Thyroid Carcinoma

Endocrinology ◽  
2005 ◽  
Vol 146 (10) ◽  
pp. 4456-4463 ◽  
Author(s):  
Caroline S. Kim ◽  
Vasily V. Vasko ◽  
Yasuhito Kato ◽  
Michael Kruhlak ◽  
Motoyasu Saji ◽  
...  
Keyword(s):  
Thyroid Cancer ◽  
Mouse Model ◽  
Thyroid Carcinoma ◽  
Cell Motility ◽  
Follicular Thyroid Carcinoma ◽  
Common Finding ◽  
Follicular Thyroid Cancer ◽  
Akt Activation ◽  
Akt Isoforms ◽  
Phosphorylated Akt

The phosphatidylinositol 3-kinase/AKT pathway is crucial to many cell functions, and its dysregulation in tumors is a common finding. The molecular basis of follicular thyroid cancer metastasis is not well understood but may also be influenced by AKT activation. We previously created a knockin mutant mouse that expresses a mutant thyroid hormone receptor-β gene (TRβPV mouse) that spontaneously develops thyroid cancer and distant metastasis similar to human follicular thyroid cancer. In this study, we investigated whether our mouse model exhibits similar AKT activation as human follicular thyroid cancer. Western blot analysis on thyroids from both wild-type and TRβPV/PV mice revealed elevation of activated AKT in TRβPV/PV mice. Immunohistochemistry and confocal microscopy reveal activated AKT in both the thyroid and metastatic lesions of TRβPV/PV mice. Whereas all three AKT isoforms were overexpressed in primary tumors from TRβPV/PV mice in the cytoplasm of thyroid cancer cells, only AKT1 was also found in the nucleus, matching the localization of activated AKT in a pattern similar to human follicular thyroid cancer. In the metastases, all AKT isoforms correlated with phosphorylated AKT nuclear localization. We created primary thyroid cell lines derived from TRβPV/PV mice and found reduction of phosphorylated AKT levels or AKT downstream targets diminishes cell motility. Activated AKT is common to both human and mouse follicular thyroid cancer and is correlated with increased cell motility in vitro and metastasis in vivo. Thus, TRβPV/PV mice could be used to further dissect the detailed pathways underlying the progression and metastasis of follicular thyroid carcinoma.

scholarly journals Atypical Presentation as Unilateral Renal and Soft Tissue Metastases from Follicular Carcinoma Thyroid

2012 ◽  
Vol 3 (3) ◽  
pp. 184-186
Author(s):  
S Kumar ◽  
Ambikavathy Mohan ◽  
Udaya Kumar
Keyword(s):  
Thyroid Cancer ◽  
Soft Tissue ◽  
Thyroid Carcinoma ◽  
Left Kidney ◽  
Follicular Carcinoma ◽  
Distant Metastases ◽  
Needle Aspiration ◽  
Atypical Presentation ◽  
Follicular Thyroid Cancer ◽  
Follicular Carcinoma Thyroid

ABSTRACT Thyroid carcinoma comprises 1% of all malignancies. Follicular thyroid carcinoma is the second most common cancer of thyroid. Vascular invasion and hematogenous metastases to bone, lungs, brain, skin and adrenal glands has a reported incidence of 11 to 25%. The initial presentation of the patient with distant metastases is rare. Well-differentiated thyroid cancers with renal secondaries are reported in limited number of cases so far. W e report a case of an asymptomatic female patient who presented to us with soft tissue metastases to scalp, left sc apular regio n an d left k idn ey. On furth er evalu atin g, ultrasound of the neck showed a solitary nodule of 2 × 1 cm in the left lobe of thyroid. Fine needle aspiration cytology (FNAC) of thyroid reported as follicular carcinoma. FNAC of scalp, scapular swelling, and left kidney lesion was reported as metastatic lesions from follicular thyroid cancer. The patient refused any surgical intervention and she received three cycles of chemotherapy and suppressive treatment with L-thyroxine. She is on regular follow-up with the stable disease till date. We present this case for its rarity of renal metastases from follicular thyroid cancer. How to cite this article Mohan A, Kumar S, Kumar U. Atypical Presentation as Unilateral Renal and Soft Tissue Metastases from Follicular Carcinoma Thyroid. Int J Head and Neck Surg 2012;3(3):184-186.

Evaluation of oxidative stress in patients of follicular thyroid cancer and study the therapeutic effect of Resveratrol on oxidative stress in FTC-133 thyroid cancer cell line

2019 ◽  
Vol 9 (o3) ◽  
Author(s):  
BasmaTalib Al-Sudani ◽  
Suhad Faisal Hatem Al-Mugdadi ◽  
Ahmed Ali Mohammed
Keyword(s):  
Oxidative Stress ◽  
Thyroid Cancer ◽  
Thyroid Carcinoma ◽  
Cell Line ◽  
Therapeutic Effect ◽  
Follicular Thyroid Carcinoma ◽  
Cancer Cell Line ◽  
Thyroid Cancer Cell ◽  
Follicular Thyroid Cancer ◽  
Thyroid Cancer Cell Line

The second most common cancer of the Thyroid gland is FollicularThyroid Carcinoma (FTC), second only to papillary carcinoma. Resveratrol, a natural polyphenolic compound that has anti- oxidative, anti-inflammatory and apoptotic properties, appears to have substantial cardio protection and cancer-prevention properties. Furthermore, resveratrol is thought to be responsible for regulating several biological processes, such as metabolism and aging, through the modulation of the mammalian silent information regulator 1 (SIRT1) of the Sirtuins family. The purpose of this study is evaluating erythrocyte malondialdehyde’s (MDA) role in the indication of the oxidative status in follicular thyroid carcinoma patients and investigating the therapeutic effect of resveratrol, a potent antioxidant, upon oxidative stress levels in thyroid cancer in vitro.Malondialdehyde was evaluated in erythrocyte of follicular thyroid cancer patients after and before treatment with sodium stibogluconate .Cytotoxicity by MTT assay and intracellular reactive oxygen species (ROS) levels was measured after resveratrol treatment on follicular thyroid carcinoma FTC-133 cell line. The results of this study confirmed that150 μM Resveratrol inhibited proliferation of FTC-133 thyroid cancer cell line in vitro by 88% after 72hand treatment with 50-200μM Resveratrol reduced ROS levels.To sum up,considering its mode of action, resveratrol might have an important role providing a source for natural antitumor agents, a fact that would have great therapeutic potential in integrated oncology.

Sign in / Sign up

Export Citation Format

Share Document